Skip to content

Comparison of Extra Virgin Olive Oil and Canola Oil in Treatment of Patients with Ulcerative Colitis(UC)

Comparison of Extra Virgin Olive Oil and Canola Oil on Clinical Outcomes and Inflammatory Markers (hsCRP, TNF-a) among Patients with Ulcerative Colitis(UC)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170730035381N1
Enrollment
32
Registered
2017-12-28
Start date
2018-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis. Ulcerative colitis

Interventions

Intervention 1: Extra virgin olive oil
50 ml once daily
Crossover intervention for 20 days and 14 days wash out
with food in raw form (no frying and cooking oil)
Aryan Tame Khazar Co. Intervention 2: Intervention group: Canola oil
Aryan Tame Khazar Co.
Treatment - Other
Intervention group: Canola oil

Sponsors

Vice Chancellor for Research and Technology of Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Ulcerative colitis, confirmed by histopathology The severity of the disease is mild to moderate Non-infectious, autoimmune and inclusive diseases (including cancer, kidney disease, rheumatoid arthritis, liver, AIDS, and cardiovascular disease) No use of ?3 supplements, fish oil Body mass index ranges from 18.5 to 30 The patient should not be pregnant or breastfeeding The age range is between 18 and 75 years old People's Inclination to collaborate on the plan

Exclusion criteria

Exclusion criteria: The patient is in the acute phase of the disease The patient does not tolerate the recommended oils reluctancy to continue cooperation in this research

Design outcomes

Primary

MeasureTime frame
Serum hs-CRP. Timepoint: The beginning of the study - the end of the twentieth day. Method of measurement: ELISA.;Serum TNF-a. Timepoint: The beginning of the study - the end of the twentieth day. Method of measurement: ELISA.;Serum ESR. Timepoint: The beginning of the study - the end of the twentieth day. Method of measurement: ELISA.;Stool frequency per day. Timepoint: The beginning of the study - the end of the twentieth day. Method of measurement: Mayo score.;Frequency of rectal bleeding per day. Timepoint: The beginning of the study - the end of the twentieth day. Method of measurement: Mayo score.

Secondary

MeasureTime frame
Weight. Timepoint: The beginning of the study - the end of the twentieth day. Method of measurement: Scales.;Body mass index. Timepoint: The beginning of the study - the end of the twentieth day. Method of measurement: BMI by formula.;Waist circumference. Timepoint: The beginning of the study - the end of the twentieth day. Method of measurement: Non stretch meter.;Hip circumference. Timepoint: The beginning of the study - the end of the twentieth day. Method of measurement: Non stretch meter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrnaz Morvaridi

Ahvaz Jundishapur University of Medical Sciences

morvaridi.m@ajums.ac.ir+98 61 3221 6104

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026